Interleukin-1 Blockade with RPH-104 (Goflikicept) in Patients with ST-Segment Elevation Myocardial Infarction: Secondary End Points from an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study
Abbate A.,
Van Tassell B.,
Bogin V.,
Markley R.,
Pevzner D.V.,
Cremer P.C.,
Meray I.A.,
Privalov D.V.,
Taylor A.,
Grishin S.A.,
Egorova A.N.,
Ponomar E.G.,
Lavrovsky Y.,
Samsonov M.Y.
Связанные документы (рекомендация CORE)